Cell senescence in myxoid/round cell liposarcoma

Sarcoma

Volumn 2014, Issue , 2014, Pages

  Kåbjörn Gustafsson, Christina ^a   Ståhlberg, Anders ^a   Engtröm, Katarina ^a   Danielsson, Anna ^a   Turesson, Ingela ^b   Åman, Pierre ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CYCLIN A2; FUSED IN SARCOMA PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1 GAMMA; INTERLEUKIN 8 RECEPTOR; KI 67 ANTIGEN; PROTEIN P130; PROTEIN P15; PROTEIN P53; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CELL AGING; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; ENZYME ACTIVITY; GROWTH RATE; GROWTH REGULATION; HETEROCHROMATIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MYXOID CELL SARCOMA; MYXOSARCOMA; ONCOGENE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ROUND CELL LIPOSARCOMA;

EID: 84904097000     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2014/208786     Document Type: Article

References (38)

1. Fletcher C. D., Unni K. K., Mertens F., Tumors of Soft Tissue and Bone. WHO Classification Pathology and Genetics 2000 Lyon, France IARCPress
2. Crozat A., Aman P., Mandahl N., Ron D., Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993 363 6430 640 644 2-s2.0-0027227651 10.1038/363640a0 (Pubitemid 23227627)
3. Rabbitts T. H., Forster A., Larson R., Nathan P., Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genetics 1993 4 2 175 180 2-s2.0-0027276357 10.1038/ng0693-175 (Pubitemid 23179103)
4. Åman P., Ron D., Mandahl N., Fioretos T., Heim S., Arheden K., Willen H., Rydholm A., Mitelman F., Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes and Cancer 1992 5 4 278 285 2-s2.0-0026621537 10.1002/gcc.2870050403 (Pubitemid 23011197)
5. Panagopoulos I., Höglund M., Mertens F., Mandahl N., Mitelman F., Åman P., Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996 12 3 489 494 2-s2.0-0030029073 (Pubitemid 26059642)
6. Riggi N., Cironi L., Provero P., Suvà M.-L., Stehle J.-C., Baumer K., Guillou L., Stamenkovic I., Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Research 2006 66 14 7016 7023 2-s2.0-33746924453 10.1158/0008-5472.CAN-05-3979 (Pubitemid 44197677)
7. Zinszner H., Albalat R., Ron D., A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes and Development 1994 8 21 2513 2526 2-s2.0-0027970712 (Pubitemid 24347243)
8. Zinszner H., Immanuel D., Yin Y., Liang F.-X., Ron D., A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene 1997 14 4 451 461 2-s2.0-0031035765 (Pubitemid 27087108)
9. Göransson M., Andersson M. K., Forni C., Ståhlberg A., Andersson C., Olofsson A., Mantovani R., Åman P., The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF- B target genes by interaction with NFKBIZ. Oncogene 2009 28 2 270 278 2-s2.0-58249116717 10.1038/onc.2008.378
10. Göransson M., Elias E., Ståhlberg A., Olofsson A., Andersson C., Åman P., Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP β -mediated interleukin 6 expression. International Journal of Cancer 2005 115 4 556 560 2-s2.0-18544379762 10.1002/ijc.20893 (Pubitemid 40656712)
11. Killela P. J., Reitmana Z. J., Jiao Y., TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proceedings of the National Academy of Sciences of the United States of America 2013 110 15 6021 6026
12. Barretina J., Taylor B. S., Banerji S., Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nature Genetics 2010 42 8 715 721
13. Olofsson A., Willén H., Göransson M., Engström K., Meis-Kindblom J. M., Stenman G., Kindblom L.-G., Aman P., Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas. International Journal of Oncology 2004 25 5 1349 1355 2-s2.0-16644397236
14. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A. H. F. M., Schlegelberger B., Stein H., Dörken B., Jenuwein T., Schmitt C. A., Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005 436 7051 660 665 2-s2.0-23244461708 10.1038/nature03841 (Pubitemid 41117262)
15. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.-V. F., Kolettas E., Niforou K., Zoumpourlis V. C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C. L., Dyrskjot L., Ørntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T. D., Bartek J., Gorgoulis V. G., Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006 444 7119 633 637 2-s2.0-33845235459 10.1038/nature05268 (Pubitemid 44864442)
16. Braig M., Schmitt C. A., Oncogene-induced senescence: putting the brakes on tumor development. Cancer Research 2006 66 6 2881 2884 2-s2.0-33645526114 10.1158/0008-5472.CAN-05-4006
17. Yaswen P., Campisi J., Oncogene-induced senescence pathways weave an intricate tapestry. Cell 2007 128 2 233 234 2-s2.0-33846334501 10.1016/j.cell.2007.01.005 (Pubitemid 46123519)
18. Engström K., Willén H., Kåbjörn-Gustafsson C., Andersson C., Olsson M., Göransson M., Järnum S., Olofsson A., Warnhammar E., Åman P., The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. American Journal of Pathology 2006 168 5 1642 1653 2-s2.0-33646535436 10.2353/ajpath.2006.050872
19. Thelin-Jarnum S., Lassen C., Panagopoulos I., Mandahl N., Aman P., Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. International Journal of Cancer 1999 83 1 30 33 (Pubitemid 29409472)
20. Yokoi T., Miyawaki T., Yachie A., Kato K., Kasahara Y., Taniguchi N., Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 1990 70 1 100 105 2-s2.0-0025233963 (Pubitemid 20148070)
21. Köpf I., Hanson C., Delle U., Verbiené I., Weimarck A., A rapid and simplified technique for analysis of archival formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization (FISH). Anticancer Research 1996 16 5 2533 2536 2-s2.0-0029964845 (Pubitemid 26388213)
22. Yoshida H., Nagao K., Ito H., Yamamoto K., Ushigome S., Chromosomal translocations in human soft tissue sarcomas by interphase fluorescence in situ hybridization. Pathology International 1997 47 4 222 229 2-s2.0-0030897054 (Pubitemid 27164311)
23. Helmbold H., Deppert W., Bohn W., Regulation of cellular senescence by Rb2/p130. Oncogene 2006 25 38 5257 5262 2-s2.0-33748080443 10.1038/sj.onc. 1209613 (Pubitemid 44299085)
24. Fiorentino F. P., Symonds C. E., MacAluso M., Giordano A., Senescence and p130/Rbl2: a new beginning to the end. Cell Research 2009 19 9 1044 1051 2-s2.0-69949139354 10.1038/cr.2009.96
25. Haferkamp S., Tran S. L., Becker T. M., Scurr L. L., Kefford R. F., Rizos H., The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging 2009 1 6 542 556 2-s2.0-77952779168
26. Helmbold H., Kömm N., Deppert W., Bohn W., Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene 2009 28 39 3456 3467 2-s2.0-70349693968 10.1038/onc.2009.222
27. Helmbold H., Galderisi U., Bohn W., The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence. Journal of Cellular Physiology 2012 227 2 508 513 2-s2.0-82155188547 10.1002/jcp.22786
28. Adams P. D., Remodeling chromatin for senescence. Aging Cell 2007 6 4 425 427 2-s2.0-34447636233 10.1111/j.1474-9726.2007.00313.x (Pubitemid 47087048)
29. Zhang R., Chen W., Adams P. D., Molecular dissection of formation of senescence-associated heterochromatin foci. Molecular and Cellular Biology 2007 27 6 2343 2358 2-s2.0-33947236204 10.1128/MCB.02019-06 (Pubitemid 46418486)
30. Giri D., Ittmann M., Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. American Journal of Pathology 2001 159 1 139 147 2-s2.0-0035404541 (Pubitemid 33704200)
31. Giri D., Ozen M., Ittmann M., Interleukin-6 is an autocrine growth factor in human prostate cancer. American Journal of Pathology 2001 159 6 2159 2165 2-s2.0-0035180451 (Pubitemid 33104270)
32. Kawano M. M., Ishikawa H., Tsuyama N., Growth mechanism of human myeloma cells by interleukin-6. International Journal of Hematology 2002 76 supplement 1 329 333
33. Nakanishi H., Yoshioka K., Joyama S., Araki N., Myoui A., Ishiguro S., Ueda T., Yoshikawa H., Itoh K., Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. American Journal of Pathology 2004 165 2 471 480 2-s2.0-3242760481 (Pubitemid 38971377)
34. Acosta J. C., O'Loghlen A., Banito A., Guijarro M. V., Augert A., Raguz S., Fumagalli M., Da Costa M., Brown C., Popov N., Takatsu Y., Melamed J., d'Adda di Fagagna F., Bernard D., Hernando E., Gil J., Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008 133 6 1006 1018 2-s2.0-44649120132 10.1016/j.cell.2008.03.038 (Pubitemid 351795610)
35. Acosta J. C., O'Loghlen A., Banito A., Raguz S., Gil J., Control of senescence by CXCR2 and its ligands. Cell Cycle 2008 7 19 2956 2959 2-s2.0-53649100260
36. Kuilman T., Peeper D. S., Senescence-messaging secretome: SMS-ing cellular stress. Nature Reviews Cancer 2009 9 2 81 94 2-s2.0-58849154235 10.1038/nrc2560
37. Engström K., Bergh P., Cederlund C.-G., Hultborn R., Willen H., Åman P., Kindblom L.-G., Meis-Kindblom J. M., Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncologica 2007 46 6 838 845 2-s2.0-34547177837 10.1080/02841860601080415 (Pubitemid 47123772)
38. von Wangenheim K.-H., Peterson H.-P., Schwenke K., A major component of radiation action: interference with intracellular control of differentiation. International Journal of Radiation Biology 1995 68 4 369 388 2-s2.0-0028970681